Implantica publishes Interim Report January - June 2026 (Q2)

VADUZ, Liechtenstein, Aug. 21, 2026 /PRNewswire/ -- FDA Approval of RefluxStop® - Strategic Preparation Sets the Stage for Success Significant events in the second quarter of 2026 RefluxStop® sales increased by more than 60% compared with the prior-year period, reflecting continued...